Abivax 2022 Financial Communication Calendar

3 years ago

PARIS, FRANCE / ACCESSWIRE / January 25, 2022 / Abivax SA (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company…

West Island Closes on 1st Tranche of Private Placement

3 years ago

Toronto, Ontario--(Newsfile Corp. - January 25, 2022) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) ("West Island"…

AgeTech Startup, AskAnnie.ai, Is Launching a Voice-First Digital Assistant for Home Health and Home Care

3 years ago

Chicago, Illinois--(Newsfile Corp. - January 25, 2022) - A Chicago-based startup is launching a voice-first digital assistance platform that will…

​​Atlas Health Raises $40M Series A to Expand AI-Powered Patient Advocacy Solution

3 years ago

Investment in philanthropic medical financial aid solution empowers hospitals and health systems to help more patients access and afford care…

AIROS Medical and Fist Assist Devices, LLC Announce Launch of Commercial Website for Fist Assist FA-1 Wearable Medical Device

3 years ago

LAS VEGAS--(BUSINESS WIRE)--AIROS Medical, Inc., a designer, manufacturer, and distributor of compression therapy devices, and Fist Assist Devices, LLC (Fist…

Neuropathix, Inc. Welcomes Daniele Piomelli, PhD, MD to the Company’s Scientific Advisory Board

3 years ago

DOYLESTOWN, PA / ACCESSWIRE / January 25, 2022 / Neuropathix, Inc. ("Neuropathix" or the "Company") (OTCQB:NPTX), a socially responsible pain…

Jupiter Wellness Announces Board Approval of $5.0 Million Share Buyback Program

3 years ago

Represents Approximately 30% of Jupiter Wellness's Outstanding Shares at current market priceJUPITER, FL / ACCESSWIRE / January 25, 2022 /…

Chiesi USA Announces New Publication of Post Hoc Analysis on Timing of Ischemic Events in Cardiac Patients and Role of KENGREAL® (cangrelor) in Reducing Risk

3 years ago

Post hoc analysis of the CHAMPION PHOENIX clinical trial demonstrates that the majority of ischemic events occurred early in percutaneous…

Rakovina Therapeutics President to Join Expert Panel at the Fifth Annual DDR, ATR & PARP Inhibitors Summit

3 years ago

VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV:RKV) (“the Company”), a biopharmaceutical company committed to…

INmune Bio, Inc. Announces Research Collaboration with Chinese University of Hong Kong to Evaluate INKmune in Nasopharyngeal Cancer

3 years ago

Boca Raton, Florida, Jan. 25, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (“INMB” or “the Company”), a clinical-stage immunology company…